Subclinical pulmonary involvement assessed by broncho-alveolar lavage in patients with early undifferentiated connective tissue disease

Clinical and Experimental Rheumatology

Volumn 19, Issue 5, 2001, Pages 551-559

  Kumanovics G ^a   Zibotics, H ^a   Juhasz E ^a   Komocsi A ^a   Czirjak L ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Alveolitis; Bronchoalveolar lavage; Early undifferentiated connective tissue disease; Lung fibrosis; Systemic sclerosis

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DISEASE DURATION; EVALUATION; FEMALE; FIBROSING ALVEOLITIS; GRANULOCYTE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMAN CELL; LEUKOCYTE DIFFERENTIAL COUNT; LUNG ALVEOLITIS; LUNG DISEASE; LUNG FUNCTION TEST; LUNG LAVAGE; LYMPHOCYTE; LYMPHOCYTE COUNT; MALE; NEUTROPHIL; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

ADULT; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; NEUTROPHILS; PULMONARY FIBROSIS; RADIOGRAPHY, THORACIC; RESPIRATORY FUNCTION TESTS; SCLERODERMA, SYSTEMIC; T-LYMPHOCYTE SUBSETS;

EID: 0034828080     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Early undifferentiated connective tissue disease. I. Early clinical manifestation in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of well established connective tissue disease
2. Early undifferentiated connective tissue disease. II. The frequency of circulating antinuclear antibodies in patients with early rheumatic diseases
3. Undifferentiated connective tissue syndromes
4. Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis)
5. Early undifferentiated connective tissue disease (CTD). VI. An inception cohort after 10 years: Disease remissions and changes in diagnoses in well established and undifferentiated CTD
6. Systemic lupus erythematosus: Predictors of its occurrence among a cohort of patients with early undifferentiated connective tissue disease: Multivariate analyses and identification of risk factors
7. Undifferentiated connective tissue diseases: The clinical and serological profiles of 91 patients followed for at least 1 year
8. Early undifferentiated connective tissue disease. V. An inception cohort 5 years later: Disease remissions and changes in diagnoses in well established and undifferentiated connective tissue diseases
9. Early detection of connective tissue disease in patients with Raynaud's phenomenon
10. Early arthritides: Nosography, nosology, and diagnostic criteria
11. The prognosis of rheumatoid arthritis and undifferentiated polyarthritis syndrome in the clinic: A study of 1141 patients
12. The diagnostic value of several immunological tests for anti-nuclear antibody in predicting the development of connective tissue disease in patients presenting with Raynaud's phenomenon
13. Early undifferentiated connective tissue disease. IV. Musculoskeletal manifestations in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of patients with tissue diseases: Followup analyses in patients with unexplained polyarthritis and patients with rheumatoid arthritis at baseline
14. Undifferentiated connective tissue diseases (UCTD): A review of the literature and a proposal for preliminary classification criteria
15. Pulmonary diffusing capacity disturbances are related to nailfold capillary changes in patients with Raynaud's phenomenon with and without an underlying connective tissue disease
16. High resolution computed tomography for the evaluation of lung involvement in 101 patients with scleroderma
17. Predictors of survival in 171 patients with systemic sclerosis (scleroderma)
18. Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage. Relationship between alveolitis and subsequent changes in lung function
19. 99mTc-DTPA clearance
20. Investigation of the alveolar macrophages and T lymphocytes in 15 patients with systemic sclerosis
21. Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis
22. Subclinical alveolitis in immunological systemic disorders. Transition between health and disease?
23. Neutrophil activation in fibrosing alveolitis: A comparison of lone cryptogenic fibrosing alveolitis and systemic sclerosis
24. Fibrosing alveolitis in systemic sclerosis. Bronchoalveolar lavage findings in relation to computed tomographic appearance
25. Interleukin 6 secretion by monocytes and alveolar macrophages in systemic sclerosis with lung involvement
26. Bilateral bronchoalveolar lavage in progressive systemic sclerosis: Interlobar variability, lymphocyte subpopulations, and functional correlations
27. Inhibitory effect of sera on the thyroid 5-deiodinase activity in systemic sclerosis
28. Undifferentiated, overlapping, and mixed connective tissue diseases
29. Classification and diagnostic criteria for mixed connective tissue disease
30. Preliminary criteria for the classification of systemic sclerosis (scleroderma)
31. Wide-field capillary microscopy
32. Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases
33. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis
34. Standardized function testing. Report of working party on standardized lung function tests
35. Clinical and subclinical alveolitis in connective tissue diseases assessed by bronchoalveolar lavage
36. A prospective study of Raynaud phenomenon and early connective tissue disease. A five-year report
37. Diagnosis of alveolitis in interstitial lung manifestation in connective tissue diseases: Importance of late inspiratory crackles, 67 gallium scan and bronchoalveolar lavage
38. Correlation between functional and radiographic data, and broncho-alveolar cytology in patients with diffuse interstitial lung disease
39. Pulmonary involvement in progressive systemic sclerosis: Sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage
40. Fibrosing alveolitis in systemic sclerosis: Indices of lung function in relation to extent of disease on computed tomography
41. Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung
42. Serological markers in progressive systemic sclerosis: Clinical correlations
43. Immunogenetic prediction of pulmonary fibrosis in systemic sclerosis
44. Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis
45. Prediction of five-year survival following presentation with scleroderma: Development of a simple model using three disease factors at first visit
46. Skewing of the CD8+ T-cell repertoire in the lungs of patients with systemic sclerosis
47. Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis
48. A pilot study of intermittent intravenous cyclophosphamide for the treatment of systemic sclerosis associated lung disease
49. Intravenous cyclophosphamide pulse therapy for the treatment of lung disease associated with scleroderma
50. Therapy for severe interstitial lung disease in systemic sclerosis. A retrospective study
51. Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide